Stocks Higher as In...
Health Care: Health Services
Enzo Biochem Inc. (ENZ: NYSE)
$2.29 0.09 | 4.09%
06/18/13 - 04:04 PM ET
Company Balance Sheet
| Jul 2012 | Jul 2011 | Jul 2010 | Jul 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 15.08M | 14.16M | 8.76M | 6.93M |
| Receivables | 14.14M | 15.24M | 13.01M | 12.48M |
| Inventories | 8.80M | 9.26M | 8.88M | 9.26M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 40.37M | 51.40M | 57.74M | 74.46M |
| Property, Plant & Equipment, Gross | 31.60M | 31.19M | 29.46M | 27.24M |
| Accumulated Depreciation & Depletion | 22.48M | 20.86M | 17.61M | 15.92M |
| Property, Plant & Equipment, Net | 9.12M | 10.34M | 11.86M | 11.32M |
| Intangibles | 11.78M | 19.98M | 20.37M | 22.01M |
| Other Non-Current Assets | 407.00K | 382.00K | 338.00K | 439.00K |
| Total Non-Current Assets | 28.76M | 58.08M | 57.51M | 58.67M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 69.12M | 109.47M | 115.24M | 133.13M |
| Accounts Payable | 9.02M | 7.86M | 6.46M | 4.24M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 118.00K | 1.68M | 572.00K | 1.06M |
| Total Current Liabilities | 18.96M | 17.73M | 15.56M | 13.94M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 938.00K | 2.93M | 2.58M | 2.37M |
| Other Non-Current Liabilities | 128.00K | 96.00K | 90.00K | 38.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 1.07M | 3.03M | 2.67M | 2.40M |
| Total Liabilities | 20.02M | 20.76M | 18.23M | 16.35M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 49.10M | 88.72M | 97.02M | 116.78M |
| Common Par | 395.00K | 390.00K | 388.00K | 386.00K |
| Additional Paid In Capital | 304.36M | 305.83M | 306.56M | 306.28M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -254.18M | -214.91M | -201.95M | -179.72M |
| Treasury Stock | -3.07M | -6.39M | -8.85M | -10.44M |
| Other Equity Adjustments | 1.60M | 3.79M | 875.00K | 276.00K |
| Total Capitalization | 49.10M | 88.72M | 97.02M | 116.78M |
| Total Equity | 49.10M | 88.72M | 97.02M | 116.78M |
| Total Liabilities & Stock Equity | 69.12M | 109.47M | 115.24M | 133.13M |
| Total Common Shares Outstanding | 39.28M | 38.60M | 38.16M | 38.59M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 216.56K | 450.01K | 623.85K | 735.55K |
| Basic Weighted Shares Outstanding | 38.80M | 38.36M | 38.00M | 37.51M |
| Diluted Weighted Shares Outstanding | 38.80M | 38.36M | 38.00M | 37.51M |
| Number of Employees | 467 | 535 | 527 | 539 |
| Number of Part-Time Employees | 64 | 71 | 62 | 75 |
Portfolios with ENZ
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserBarron's Insider Purchases ...
- ContributorStockerblog.com Gene Therap...
- Userkelvinenz Portfolio 1
- UserS-0022
- UserTraderSteveUK Portfolio 1
- UserRT_in_CA
- UserSo far, I'm beating the S&a...
Latest ENZ Headlines from TheStreet
- Interesting ENZ Call For January 2014 05.20.13 | 12:05 pm
- 4 Big Volume Gainers Under $10 11.13.12 | 06:11 pm
- 5 Stocks Poised for Breakouts 09.21.12 | 12:09 pm
- Thursday Earnings Live Blog 10.14.10 | 04:10 pm
- Investors May See Upside Down Under 09.16.10 | 08:09 am
- Enzo Biochem 1Q Loss Narrows On Revenue Boost 12.10.09 | 04:12 pm
- Enzo Biochem 4Q Loss Widens On Costs 10.14.09 | 06:10 pm
- Tuesday's Health Winners & Losers 10.16.07 | 04:10 pm
- Enzo Biochem Falls on Court Dismissal 09.07.07 | 02:09 pm
- Friday's Health Winners & Losers 09.07.07 | 02:09 pm
Press Releases for ENZ
- Enzo Biochem Reports Fiscal Second Quarter Results - Business Wire 03.12.13 | 04:03 pm
- Enzo Biochem Schedules Teleconference To Discuss Second Quarter Results On March 13, 2013 At 8:30 AM E.T. - Business Wire 03.08.13 | 01:03 pm
- Enzo Biochem Reports First Quarter Results - Business Wire 12.10.12 | 04:12 pm
- Enzo Biochem Schedules Teleconference To Discuss First Quarter Results On December 11, 2012 At 8:30 AM E.T. - Business Wire 12.06.12 | 11:12 am
- Enzo Biochem To Present At Canaccord Genuity 2012 Medical Technology & Diagnostics Forum - Business Wire 11.29.12 | 03:11 pm
- Enzo Biochem’s Clinical Labs Introduces Diagnostic Test That Assists In Early Detection Of Lung Cancer - Business Wire 11.13.12 | 07:11 am
- Enzo Biochem To Present At Lazard Capital Markets 9th Annual Healthcare Conference - Business Wire 11.12.12 | 11:11 am
- Enzo Biochem Reports Jury Declares Life Technologies Infringed Company Patents And Awards Enzo $48.6 Million - Business Wire 11.02.12 | 09:11 am
- Enzo Biochem Reports Fourth Quarter Results And Announces Realignment Program Expected To Reduce Annualized Costs $6 Million Commencing With Fiscal First Quarter - Business Wire 10.15.12 | 04:10 pm
- Enzo Biochem Schedules Teleconference To Discuss Fourth Quarter Results On October 16, 2012 At 8:30 AM E.T. - Business Wire 10.12.12 | 03:10 pm
Partner Headlines for ENZ
- Pre-Market Earnings Report for December 11, 2012 : DG, PTRY, ENZ, HSOL - NASDAQ 12.10.12 | 09:12 pm
- Investors Should Wait Out Quest & LabCorp - Seeking Alpha 02.16.12 | 09:02 am
- Enzo Biochem: Personalized Medicine Is More Than Targeted Therapeutics - Seeking Alpha 04.03.11 | 07:04 am
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
- Top 5 Percentage Gainers On NYSE (DV, CKH, ENZ, LAD, CMG) - Benzinga 07.23.10 | 03:07 pm
- MB FINANCL INC (MBFI) - Profit Tracks - Zacks 04.13.10 | 01:04 am
- UPDATE 2-Enzo wins round in Applera patent fight - Reuters 03.26.10 | 04:03 pm
